We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Top Buys

1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$2.75M
2
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$2.47M
3
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$2.28M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2M
5
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$1.99M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131K
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$113K
3
VUG icon
Vanguard Growth ETF
VUG
+$104K
4
VT icon
Vanguard Total World Stock ETF
VT
+$103K
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$97.9K

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBT
651
Beacon Financial Corp
BBT
$2.58B
– –
-42
Closed -$2K
BLUE
652
DELISTED
bluebird bio
BLUE
– –
0
– -$1K
BOKF icon
653
BOK Financial
BOKF
$8.58B
– –
-12
Closed -$1K
BR icon
654
Broadridge
BR
$17.3B
– –
-11
Closed -$1K
CACI icon
655
CACI
CACI
$10.2B
– –
-13
Closed -$2K
CAL icon
656
Caleres
CAL
$398M
– –
-52
Closed -$2K
CATY icon
657
Cathay General Bancorp
CATY
$4.2B
– –
-72
Closed -$3K
CENTA icon
658
Central Garden & Pet Co Class A
CENTA
$2.4B
– –
-38
Closed -$1K
CFR icon
659
Cullen/Frost Bankers
CFR
$10.2B
– –
-21
Closed -$2K
CHRD icon
660
Chord Energy
CHRD
$7.21B
– –
-70
Closed -$1K
CIVI
661
DELISTED
Civitas Resources
CIVI
$0 ﹤0.01%
5
– –
CLDX icon
662
Celldex Therapeutics
CLDX
$2.77B
$0 ﹤0.01%
+3
New +$40
COHR icon
663
Coherent
COHR
$54.3B
– –
-41
Closed -$2K
CPB icon
664
Campbell Soup
CPB
$6.58B
$0 ﹤0.01%
10
– –
CPF icon
665
Central Pacific Financial
CPF
$1.02B
– –
-54
Closed -$2K
CRBP icon
666
Corbus Pharmaceuticals
CRBP
$167M
– –
-3
Closed -$1K
CRIS icon
667
Curis
CRIS
$9.02M
– –
0
– –
CTXR icon
668
Citius Pharmaceuticals
CTXR
$13.6M
– –
0
– –
CVS icon
669
CVS Health
CVS
$137B
$0 ﹤0.01%
2
-53
-96% -$3.49K
CXT icon
670
Crane NXT
CXT
$2.95B
– –
-49
Closed -$2K
CZR icon
671
Caesars Entertainment
CZR
$6.08B
– –
-66
Closed -$2K
DAR icon
672
Darling Ingredients
DAR
$10B
– –
-72
Closed -$1K
DBO icon
673
Invesco DB Oil Fund
DBO
$385M
$0 ﹤0.01%
10
– –
DCI icon
674
Donaldson
DCI
$10.5B
– –
-13
Closed -$1K
DGX icon
675
Quest Diagnostics
DGX
$23.3B
$0 ﹤0.01%
2
– –
25 26
27
28 29

Similar funds

VWM
Venturi Wealth Management Austin, Texas $2.22B AUM 24.65% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.23B AUM 15.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.